// App-Quantinova.ai

3489 : Peripheral Neuropathy Symptoms, Pain and Functioning in Relapsed or Refractory Multiple Myeloma Patients Treated with Selinexor, Bortezomib, and Dexamethasone

Researchers

Presenter

  • Larysa Sanchez

Principal Investigators

  • Jennifer Beaumont

  • Hailin Yu

  • Stacie Hudgens

  • Holger W Auner

  • Hang Quach

  • Sosana Delimpasi

  • Ivan Spicka

  • Ludek Pour

  • Meletios A Dimopoulos

  • Halyna Pylypenko

  • Vadim A Doronin

  • Ganna Usenko

  • Roman Hajek

  • Reuben Benjamin

  • Christopher P. Venner

  • Mamta Garg

  • Don A. Stevens

  • Sundar Jagannath

  • Philippe Moreau

  • Moshe Levy

  • Nizar Bahlis

  • Thierry Facon

  • Yi Chai

  • Xiwen Ma

  • Shijie Tang

  • Hoyee Leong

  • Jatin J. Shah

  • Sharon Shacham

  • Michael G Kauffman

  • Paul G. Richardson

  • Sebastian Grosicki

Medical Centers

  • Icahn School of Medicine at Mount Sinai/Tisch Cancer Institute, New York, NY

  • CHU de Poitiers - Hôpital La Milétrie, Service d'Hématologie et Thérapie Cellulaire, Pôle Régional de Cancérologie, POITIERS, France

  • Clinical Outcomes Solutions, Tucson, AZ

  • Imperial College, London, United Kingdom

  • St Vincent's Hospital, Fitzroy, Australia

  • Department of Hematology and Bone Marrow Transplantation Unit, Evangelismos Hospital, Athens, Greece

  • First Internal Clinic - Clinic of Hematology, General University Hospital, Prague, Czech Republic

  • Department of Internal Medicine, Hematology and Oncology, University Hospital Brno, Brno, Czech Republic

  • Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Alexandra General Hospital, Athens, Greece

  • Regional Treatment and Diagnostic Hematology Center, Cherkassy Regional Oncology Dispensary of Cherkasy Regional Council, Cherkassy, Ukraine

  • Hematology Department, State Budget Healthcare Institution of Moscow, City Clinical Hospital #40 of Moscow Healthcare Department, Moscow, Russian Federation

  • City Clinical Hospital No. 4 of Dnipro City Council, City Hematology Center, Dnipro, Ukraine

  • Department of Neurosurgery, University Hospital Ostrava, Ostrava, Czech Republic

  • King's College Hosptial NHS Foundation Trust, London, United Kingdom

  • Cross Cancer Institute, University of Alberta, Edmonton, AB, Canada

  • University Hospitals Leicester NHS Trust, Leicester, United Kingdom

  • Norton Cancer Institute - St Matthews Campus, Louisville, KY

  • Icahn School of Medicine at Mount Sinai, New York, NY

  • CHU Hotel Dieu, Nantes, France

  • Baylor University Medical Center, Dallas, TX

  • University of Calgary, Arnie Charbonneau Cancer Institute, Calgary, AB, Canada

  • CHRU de Lille, Service des maladies du sang, Lille, France

  • Karyopharm Therapeutics, Newton, MA

  • Dana-Farber Cancer Institute, Boston, MA

  • Clinical Department of Hematology and Prophylaxis of Cancer Diseases, Independent Public Healthcare Facility Municipal Hospital Group, Chórzow, Poland

Locations

  • United States

  • France

  • United Kingdom

  • Australia

  • Greece

  • Czech Republic

  • Ukraine

  • Russia

  • Canada

  • Poland

Companies

  • Clinical Outcomes So

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Peripheral neuropathy

  • Multiple Myeloma

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • Dexamethasone

  • Dekpak 13 Day Taperpak

  • Bortezomib

  • Selinexor

Outcome

  • N/A

Study Design

  • N/A

Phase

  • III

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved